PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
14-May-2025 Global Air Fluidized Therapy Beds Market to Surpass USD 1,268.1 Million by 2035, Driven by Demand for Advanced Wound Care and Long-Term Patient Support | FMI MARKITWIRED
14-May-2025 Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol ACCESS Newswire
14-May-2025 Gummi World Enters Capsule Manufacturing, Emerging as the Most Agile Full-Spectrum Supplement Manufacturer in the Industry ACCESS Newswire
14-May-2025 Stone Analysis Software Market Set to Grow at 3.0% CAGR, Reaching USD 76.8 Million by 2035 Amid Rising Urinary Stone Cases and Diagnostic Innovation | FMI MARKITWIRED
14-May-2025 Combat Dressing Market to Reach USD 7.17 Billion by 2035, Driven by Rising Military Investments and Technological Innovations | FMI MARKITWIRED
13-May-2025 ClearPoint Neuro Reports First Quarter 2025 Results ACCESS Newswire
13-May-2025 NHI Responds to ISS Recommendation ACCESS Newswire
13-May-2025 Ensysce Biosciences Reports First Quarter 2025 Financial Results ACCESS Newswire
13-May-2025 Tenon Medical Reports First Quarter 2025 Financial Results ACCESS Newswire
13-May-2025 Dr. Harrell E. Robinson Advocates for Global Access to Healthcare ACCESS Newswire
13-May-2025 Dr. Malini Saba Featured in In-Depth Spotlight Article Highlighting Her Journey from Entrepreneur to Global Changemaker ACCESS Newswire
13-May-2025 Theranexus and Beyond Batten Disease Foundation Announce Strong Positive Real-World Data Supporting Batten-1 Efficacy for the Treatment of Batten Disease ACCESS Newswire
13-May-2025 Neighborhood LTC Pharmacy Announces New Partnership With ES Gaming Powered by Easterseals ACCESS Newswire
13-May-2025 CERTIFY Health Secures Growth Equity Investment from ABS Capital Partners to Accelerate Patient Engagement Innovation ACCESS Newswire
13-May-2025 From Compliance to Transformation: Exploring the Critical Role of Healthcare Consulting Services in Shaping a Patient-Centric, Digital-First Industry Ameco Research
13-May-2025 SMC approval of BALVERSA®▼ (erdafitinib) helps pave the way for first licensed bladder cancer therapy that specifically targets fibroblast growth factor receptor (FGFR3) alterations Johnson & Johnson
13-May-2025 CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules ACCESS Newswire
13-May-2025 Hypha Labs Files Multiple Additional Patents for its Ground Breaking Mushroom Accelerator ACCESS Newswire
13-May-2025 Ankle & Foot Centers of America Shares Advice on the Best Running Shoes for National Runners Month ACCESS Newswire
13-May-2025 CenExel CEO Ryan Brooks Moderates Executive Panel at Alloy Healthcare Forum in New York City ACCESS Newswire